In May, results of the FLOW trial showed that participants with Type 2 diabetes and chronic kidney disease who received semaglutide had a 24% lower risk of having a major kidney disease event than those receiving a placebo
Both drugs are administered once a week and may cause unpleasant gastrointestinal symptoms
How Klinic Can Help Whether you ultimately choose tirzepatide, semaglutide, or want to explore other options, we at Klinic make it easier to get started with weight loss medication
Wegovy is a brand-name drug manufactured by Novo Nordisk that contains semaglutide
One study saw an improvement in the ED of 85% of subjects, regardless of whether the ED was caused by psychological or organic factors [4]
We assume that Novo Nordisk is capable of growing GLP-1 sales across indications from roughly $24 billion in 2023 to nearly $75 billion by 2031, prior to the patent expiration for semaglutide, the molecule in Ozempic and Wegovy